Appointed on June 30, 2020 - Term expires at the 2024 Shareholders’ Meeting
First appointment on June 30, 2020 (director) – April 28, 2022 (Chairman of the Board of Directors)
Number of AXA shares held on December 31, 2022: 4,268

Mr. Antoine Gosset-Grainville is a graduate of the Institut d’études politiques of Paris and holds a “DESS” (post-graduate degree) in banking and finance from the University of Paris IX Dauphine. He was admitted to the Paris Bar (2002) and the Brussels Bar (2002). After graduating from the French École nationale d’administration, he began his career, in 1993, at the Inspection Générale des Finances, before taking the position of Deputy General Secretary of the Economic and Financial Committee of the European Union in 1997. From 1999 to 2002, he was advisor for Economic and Industry Affairs in the office of the European Commissioner in charge of Trade. In 2002, he became partner at Gide, where he managed the Brussels office for five years before becoming in 2007 Deputy Director of the Cabinet of the French Prime Minister, in charge of economic and financial issues and the management of the French State’s investment portfolio. In 2010, he was appointed Deputy Managing Director of the Caisse des Dépôts et Consignations in charge of finance, strategy, investments and international operations and Interim Chief Executive Officer of the Caisse des Dépôts group from February to July 2012. In April 2013, he co-founded BDGS Associés (law firm). On April 28, 2022, Mr. Antoine Gosset-Grainville was appointed Chairman of the Board of Directors of AXA.

Chairman of the Board of Directors and director: AXA

Directorships held during the last five years

Director: AXA Assurances IARD Mutuelle, AXA Assurances Vie Mutuelle, Compagnie des Alpes, Fnac Darty, Schneider Electric

Text

Composition of the Board of Directors on April 27, 2023

Meet the members of our Board of Directors and find out more about their directorship, experience and expertise.

Members of the Board of Directors

Appointed on April 28, 2022 - Term expires at the 2026 Shareholders' Meeting

Number of AXA shares held on March 12, 2023: 1,003,917

Mr. Thomas Buberl holds a Master of Economics degree from WHU Koblenz (Germany), a MBA from Lancaster University (UK) and a PhD. in Economics from the University of St Gallen (Switzerland). Mr. Thomas Buberl began his career as a consultant at the Boston Consulting Group for the banking & insurance sector and joined the Winterthur Group in 2005 (acquired by AXA in 2006), first as Chief Operating Off icer and then as Chief Marketing and Distribution Officer. He moved to Zurich Insurance Group in 2008 as Chief Executive Off icer for Switzerland. At the beginning of 2012, Mr. Thomas Buberl was appointed Chief Executive Officer of AXA Konzern AG (Germany) and member of the AXA Executive Committee. In March 2015, he also joined the AXA Management Committee and became Chief Executive Officer of the global health business line and, in January 2016, of the global life & savings business line. Since September 1, 2016, Mr. Thomas Buberl has been Chief Executive Officer and director of AXA.

Chief Executive Officer and director: AXA

Directorships held outside the AXA Group (1)

Director or member of the Supervisory Board: Bertelsmann VerwaltungsGesellschaft (BVG) (Germany), IBM (United States)

Chairman of the Board of Directors: AXA Equitable Holdings, Inc. (United States), AXA Financial, Inc. (United States), AXA Leben AG (Switzerland), AXA Versicherungen AG (Switzerland), XL Group Ltd (Bermuda)

Chairman of the Supervisory Board: AXA Konzern AG (Germany)

Director or member of the Management Committee or member of the Supervisory Board: AXA ASIA (SAS), AXA Equitable Life Insurance Company (United States), Bertelsmann SE & Co. KGaA (Germany), Equitable Financial Life Insurance Company of America (United States) (formerly known as MONY Life Insurance Company of America)

(1) Mr. Thomas Buberl requested the Board of Directors' approval before accepting new directorships in companies outside the AXA Group.

Press Release

Infographic

June 6, 2023 - AXA announces evolutions within its leadership team to prepare the launch of its next strategic plan

Management Committee

Meet our Management Committee and see how it assists the Chief Executive Officer with the operational management of the Group.

Appointed on April 28, 2022 – Term expires at the 2026 Shareholders’ Meeting

Number of AXA shares held on March 12, 2023: 419*

Mrs. Martine Bièvre graduated with a Master’s degree in law specialized in insurance law from the University of Lyon (France). From 1984 to 1988, Mrs. Martine Bièvre was a damage regulations and civil liability editor at the UAP branch in Lyon (France). Since 1988, she held various functions such as claim inspector – adjuster, at the UAP Rhône-Alpes Delegation (from 1988 to 1999), at the UAP Bassin Parisien Delegation (from 1990 to 1999), at the AXA Bourgogne Franche-Comté Region (from 1999 to 2004), at AXA Entreprises – IARD Department (from 2004 to 2011) and at AXA IARD et Partenariats (since 2011). From 2015 to 2018, she was director representing the employees on the Board of Directors of AXA France IARD. In June 2018, Mrs. Martine Bièvre was appointed director representing the employees on AXA’s Board of Directors.

Director: Caisse de retraite du personnel de l'UAP (CRUAP)

Directorship held during the last five years

Director representing the employees: AXA France IARD

*The holding of AXA shares by directors representing the employees is not mandatory.

Appointed on June 30, 2020 - Term expires at the 2024 Shareholders’ Meeting
First appointment on June 30, 2020
Number of AXA shares on March 12, 2023: 152,029 

Mrs. Helen Browne graduated in law from the University of Kent at Canterbury (United Kingdom) (English & French Law), and the University of Grenoble (France). She is a Solicitor of the Senior Courts of England and Wales and was admitted to the Paris Bar in 1994. She joined Linklaters in 1987, working in London, Brussels and Paris and then joined the Legal Department of AXA Group in 2001 as Head of Finance before taking on the role of Head of M&A in 2009. In 2014, she was appointed AXA Group Deputy General Counsel and since 2016, she has been AXA Group General Counsel. Since June 2020, Mrs. Helen Browne has been the employee shareholder representative to the AXA Board of Directors and since March 25, 2021, a member of the AXA Management Committee.

Director representing the employee shareholders: AXA

Director or member of the Supervisory Board: GIE AXA, XL Insurance Company SE (Ireland)

Member: Haut Comité Juridique de la Place Financière de Paris

Director: AXA Corporate Solutions Assurance, RESO (Russia)

Member of the AXA Compensation, Governance & Sustainability Committee

Number of AXA shares held on March 12, 2023: 2,185*

Mrs. Bettina Cramm is a graduated Medical Educator from the Martin-Luther University (Halle/Saale – Germany). She started her career in 1984 as a Medical Technical Assistant at the German Klinik of Diagnostik of Wiesbaden (Germany). In 1991, she joined German-Civil-Servants-Insurance (DBV), known today as AXA Konzern AG. From 1991 to 1994, she was Power Clerk General Private Health Insurance at DBV and from 1994 to 2002, Operational Paramedic at DBV-Winterthur Wiesbaden. From 2002 to 2007, Mrs. Bettina Cramm was a Healthcare Consultant at DBV-Winterthur. In 1995, she joined the Works Council at DBV-Winterthur and was a member of the Supervisory Board of DBV-Winterthur Health Insurance (2006-2008), member of the Supervisory Board of DBV Vermittlungsgesellschaft für Versicherungen und Vermögensbildung mbH (2007-2008). From 2008 to 2013, and since her appointment as a director in 2018, she is responsible for the prevention and health promotion at the company medical service at AXA Konzern AG. From 2013 to June 2018, Mrs. Bettina Cramm held various functions as member of the Works Council, Central Works Council, European Works Council and their commissions and member of Supervisory Boards of AXA entities in Germany. From May 2017 to April 2022, she was a member of the Supervisory Board of AXA Konzern AG. In June 2018, Mrs. Bettina Cramm was appointed member of the Board of Directors of AXA representing the employees.

Member of the Supervisory Board: AXA Konzern AG (Germany)

Appointed on May 10, 2021 - Term expires at the 2024 Shareholders' Meeting
First appointment on May 10, 2021
Member of the AXA Audit Committee
Number of AXA shares held on January 19, 2023: 5,300

Mrs. Clotilde Delbos is graduated from EM Lyon. She began her career in California, then at Price Waterhouse in Paris before joining the Pechiney group in 1992. She held various positions in France and in Brussels in Internal Audit, Treasury and Mergers & Acquisitions to then become Division Financial Director (Bauxite Alumina and International Trade). After Pechiney’s acquisition by Alcan, Mrs. Clotilde Delbos served as Vice-President & Business Finance Director of the Engineered Products Division from 2005 up until it was sold in 2011 to Apollo Global Management (Private Equity Fund) and the Fonds Stratégique d’investissement. In the new company, Constellium, her last two positions were Deputy CFO and Chief Risk Officer. Mrs. Clotilde Delbos joined Groupe Renault in 2012 as Group Controller. On May 1, 2014, she was appointed Alliance Global Director, Control, in addition to her current role as Senior Vice-President, Groupe Renault Controller. ln April 2016, Mrs. Clotilde Delbos is appointed Executive Vice-President, Chief Financial Officer of Groupe Renault. She also became Chair of the Board of Directors of RCI Banque SA. On April 1, 2019, Mrs. Clotilde Delbos, takes over the responsibility of Internal Control on top of her current role. On October 11, 2019, the Board of Directors decides to appoint Mrs. Clotilde Delbos as Chief Executive Officer of Renault SA for an interim period until Mr. Luca de Meo takes office as Chief Executive Officer of Renault SA, and Chairman of Renault s.a.s., effective July 1, 2020. On July 1, 2020, Mrs. Clotilde Delbos became Deputy Chief Executive Officer of Groupe Renault. She remained Chief Financial Officer of Groupe Renault and Chair of the Board of Directors of RCI Banque SA. On January 1, 2021, Mrs. Clotilde Delbos is appointed Chief Executive Officer of Mobilize Brand. She remains Chief Financial Officer (until March 1, 2022), Deputy Chief Executive Off icer of Groupe Renault and Chair of the Board of Directors of RCI Banque SA and is a member of the Groupe Renault’s Board of Management up until December 31, 2022 when she has left the Groupe Renault and the RCI Banque.

 Directorships held during the last five years

Chief Executive Officer by interim: Renault SA

Chairwoman & Chief Executive Officer: RENAULT NISSAN B.V. (The Netherlands)

Chairwoman of the Board of Directors: RCI Banque

Director or member of the Supervisory Board: ALLIANCE VENTURES B.V. (The Netherlands), RENAULT Espana (Spain)

Member of the Management Board: ALLIANCE ROSTEC AUTO B.V. (The Netherlands), RENAULT Nissan B.V. (The Netherlands)

Elected on April 28, 2022 – Term expires at the 2026 Shareholders’ Meeting

Member of AXA Compensation, Governance & Sustainability Committee

Number of AXA shares held on December 31, 2022: 5,600

A native of Shanghai, Mrs. Rachel Duan holds a bachelor’s degree in Economics and International Business from Shanghai International Studies University in China and an MBA from The University of Wisconsin (Madison in USA). Mrs. Rachel Duan joined GE in 1996 and worked at GE across multiple business in the US, Japan and China. Since 2006, she has held senior leadership positions including Chief Executive Officer of GE Advanced Materials China and then Asia Pacific, Chief Executive Officer of GE Healthcare China, and Chief Executive Officer of GE China. Most recently, she served as President & Chief Executive Officer of GE Global Markets where she was responsible for driving GE’s growth in global emerging markets including China, Asia Pacific, India, Africa, Middle East and Latin America.

Director: Sanofi, Adecco Group AG (Switzerland), HSBC (United Kingdom)

President & Chief Executive Officer: GE Global Markets

Chief Executive Officer: GE China, GE Healthcare China

Appointed on April 29, 2021 - Term expires at the 2025 Shareholders' Meeting
First appointment on April 29, 2021
Chairman of the AXA Compensation, Governance & Sustainability Committee
Number of AXA shares held on March 10, 2023: 5,000

Mr. Guillaume Faury graduated from the École Polytechnique in Paris in 1990 and, subsequently, from the École nationale supérieure de l’aéronautique et de l’espace in Toulouse. Mr. Guillaume Faury began his career in 1992 as a flight-test engineer for the Eurocopter Tiger helicopter in the Direction Générale de l’Armement (DGA), the French government agency responsible for the development and purchase of defence systems for the French armed forces. Between 1998 and 2008, he held various leadership positions in engineering, programmes and flight testing in Airbus’ helicopter business, which at the time operated under the name of Eurocopter. He became Executive-Vice-President for Programmes and a member of the Eurocopter Executive Committee, before being appointed as Executive Director for Research and Development. He then spent four years in the car industry at Peugeot (2009-2013), becoming Executive Vice-President for Research and Development and a member of the company’s Management Board. From 2013 to 2018, Mr. Guillaume Faury was Chief Executive Officer of Airbus Helicopters, where his achievements included restructuring its manufacturing system and introducing new technologies. In February 2018, he became President of Airbus’ commercial aircraft business. Since April 2019, Mr. Guillaume Faury has been Chief Executive Officer of Airbus and leads the Company’s Executive Committee.

Chief Executive Officer and director: Airbus SE

Vice-President: AeroSpace and Defence Industries Association of Europe

Member of the Advisory Board: Airbus Group Ventures Fund II, L.P.

Member and First Vice-President of the Board of Directors: Groupement des Industries Françaises Aéronautiques et Spatiales

Chairman of the Board of Directors: Airbus Canada Manging GP Inc, Airbus (China) Enterprise Management and Services Co. Limited, Airbus Helicopters España, SA, Airbus Helicopters, Inc., Airbus U.S.A. 220, Inc., Fondation d'Entreprises Airbus

President: Airbus Helicopters (SAS), Airbus Helicopters Holding (SAS)

Chairman of the Supervisory Board: Airbus Operations GmbH

Managing Director (Directeur Général): Airbus

Member of the Board of Directors: Airbus Africa and Middle east FZE; Airbus Americas, Inc., Airbus Defense and Space, Inc., Airbus Defense and Space, SA, Tallano Technologies (SAS)

Member of the Supervisory Board: Airbus Helicopters Deutschland GmbH

Appointed on April 29, 2021 - Term expires at the 2025 Shareholders' Meeting
First appointment on April 29, 2021
Chairman of the AXA Finance & Risk Committee
Member of the AXA Audit Committee
Number of AXA shares held on March 29, 2023: 7,514

Mr. Ramon Fernandez is a graduate of the Institut d’études politiques in Paris (1988) and the École nationale d’administration (1993). He began his carrier at the French Treasury before joining the International Monetary Fund in Washington (from 1997 to 1999). Returning to the French Treasury, he held various important positions in different areas. He was also Advisor to the Minister of the Economy, Finance and Industry (2002-2003) and to the French President (2007-2008). In 2008, he was appointed Chief of Staff to the Minister of Labour, Social Relations, Family and Solidarity (2008-2009). From 2009 to 2014, he was Chief Executive Officer of the French Treasury, Chairman of the Agence France Trésor and Chairman of the Club de Paris. Mr. Ramon Fernandez joined Orange on September 1, 2014 as Deputy Chief Executive Officer and Group Chief Financial and Strategy Officer. In May 2, 2018, he was appointed Deputy Chief Executive Officer, Finance, Performance and Europe. From September 2020 to December 31, 2022, Mr. Ramon Fernandez was Deputy Chief Executive Officer, Finance, Performance and Development of Orange. From January 1, 2023 to March 31, 2021, Mr. Ramon Fernandez was Deputy Chief Executive Officer (Directeur Général Adjoint) of Orange. Since April 1st, 2023, Mr. Ramon Fernandez has been Group Chief Financial Officer of CMA CMG.

Chairman of the Board of Directors: Compagnie financière d’Orange Bank, Orange Bank, Orange Ventures

Member of the Board of Directors: Fondation nationale des Sciences Politiques, Institut du Capitalisme responsable, Institut Jean Monnet, Medi Telecom, Orange Middle East and Africa

Member of the Supervisory Board: Buyin, Iris Capital Management SAS, Orange Pologne

Chairman of the Board of Directors: Buyin

Member of the Board of Directors: Euronext (the Netherlands), Heuler Hermes SA, Orange Belgium

Appointed on April 28, 2022 – Term expires at the 2024 Shareholders’ Meeting
First appointment on December 14, 2016
Member of the AXA Finance & Risk Committee
Member of the AXA Compensation, Governance & Sustainability Committee
Number of AXA shares held on December 31, 2022: 7,842

Mr. André François-Poncet graduated from École des Hautes Etudes Commerciales (HEC) and holds a Master in Business Administration (MBA) from the Harvard Business School. He began his career, in 1984, at Morgan Stanley in New York and then in London and in Paris, where he was in charge of the opening of Morgan Stanley French off ice. After a sixteen-year career at Morgan Stanley, he joined, in 2000, BC Partners (Paris and London) as Managing Partner until December 2014 and then as Senior Advisor until December 2015. From September 2016 to December 2017, Mr. André François-Poncet was a Partner at the French asset manager CIAM in Paris. From January 2018 to December 2022, Mr. André François-Poncet was Group CEO of Wendel SE and Vice-Chairman of the Board of Directors of Bureau Veritas.

Chairman and Chief Executive Officer: LMBO Europe SAS

Chairman and Director: Trief Corporation (Luxembourg)

Vice-Chairman of the Board of Directors and director: Bureau Veritas

Director: Harvard Business School Club de France, Winvest Conseil (Luxembourg)

Member of the European Advisory Board: Harvard Business School

Appointed on April 28, 2022 - Term expires at the 2026 Shareholders’ Meeting
 First appointment on April 28, 2022
 Member of the Finance & Risk Committee
 Number of AXA shares held on March 12, 2023: 454,975

Mr. Gérald Harlin is a graduate of the ESSEC school of business. From 1979 to 1990, he held several positions within the Total group. He was Head of Corporate Finance Department for North America, Mining & Chemical Subsidiaries from 1989 to 1990. Mr. Gérald Harlin started working for the AXA Group in 1990 as Corporate Treasurer and became Head of Corporate Finance in 1991. In 1994, he was appointed Chief Financial Officer of AXA Asset Management Europe and its subsidiaries and Chief Executive Officer of AXA Banque. He joined AXA France in 1997 as Chief Investment Officer. In 2000 he was appointed Market Program Manager of AXA France. He became Chief Financial Officer of AXA France in 2001 until March 2003. From 2003 to 2009, Mr. Gérald Harlin was Executive Vice-President, Finance & Control of the AXA Group. From 2010 to December 2019, Mr. Gérald Harlin was Group Chief Financial Officer. During this period, he was a member of the Group’s Executive Committee (July 2008-2016) and a member of the Group’s Management Committee (July 2016-2019). In December 2017, Mr. Gérald Harlin was appointed Deputy Chief Executive Officer (Directeur Général Adjoint) in addition to his current responsibilities, until September 2020. From December 2019 to September 2020, he was appointed Executive Chairman of AXA Investment Managers, of which he is still a member of the Board of Directors.

Director: AXA, AXA France IARD, AXA France Vie, AXA Investment Managers, Catlin Insurance Company, Inc. (United States), Greenwich Insurance Company (United States), Indian Harbor Insurance Company (United States), X.L. America, Inc. (United States), XL Insurance America, Inc. (United States), XL Insurance Company of New York, Inc. (United States), XL Reinsurance America Inc. (United States), XL Select Insurance Company (United States), XL Specialty Insurance Company (United States)

Director: AXA Assurances IARD Mutuelle, AXA Assurances Vie Mutuelle, Etablissement public du Château, du musée et du domaine national de Versailles, Fondation Mérimée

Chairman & Chief Executive Officer: AXA China, AXA Investment Managers, AXA Investment Managers Paris, AXA America Holdings, Inc. (which became AXA Equitable Holdings) (United States)

Chairman of the Board of Directors: AXA France IARD, AXA France Vie, AXA Real Estate Investment      Managers, AXA Holdings Belgium SA (Belgium), AXA Mediterranean Holding S.A.U. (Spain)

Chairman of the Company and Chairman and member of the Management Committee: AXA Oeuvres d’Art, Lor Patrimoine, Oudinot Participations

Chairman and member of the Management Committee: AXA ASIA

Managing Director and member of the Management Board: Vinci B.V. (The Netherlands)

Director: AXA Global P&C, AXA Investment Managers Chorus Limited (Hong Kong), AXA Investment Managers US Inc. (United States), AXA      Equitable Life Insurance Company (United States), AXA Equitable Holdings, Inc. (United States), MONY Life Insurance Company of America (United States), XL Group Ltd (Bermuda)

Member of the Management Committee: CFP Management

Member of the Supervisory Board: AXA Liabilities Managers,

Permanent representative of: 
- AXA to the boards of AXA Global Re and AXA Investment Managers
- Société Beaujon to the board of AXA Real Estate Investment Managers

Appointed on June 30, 2020 - Term expires at the 2024 Shareholders’ Meeting
First appointment on June 30, 2020
Chairwoman of the AXA Audit Committee
Member of the AXA Finance & Risk Committee
Number of AXA shares held on January 20, 2023: 9,168

Mrs. Isabel Hudson graduated with a Master of Arts in French and German from the University of Oxford (United Kingdom). From 1981 to 1993, she held various positions at the Royal Insurance group (United Kingdom). From 1993 to 1995, she was Head of European Development and Operations at the Corporation of Lloyd’s (United Kingdom). From 1996 to 1999, she was the International Development Director for GE Insurance Holdings Ltd (United Kingdom) and from 1999 to 2002, she held the positions of Chief Financial Officer and Executive Director of Eureko BV (The Netherlands). From 2002 to 2006, she was an Executive Director of Prudential’s UK business and Chairwoman of Prudential International Assurance and from 2006 to 2008, she established and served as Chief Executive Officer of a specialized pension buyout firm Synesis Life. In June 2011, she joined the National House Building Council (NHBC) Board and was non-executive Chairwoman from November 2011 to the end of May 2020. She had also been a non-executive Director of QBE Insurance Group Ltd (Australia) for 9 years. In November 2014, she was appointed to the Board of BT Group plc (United Kingdom). Mrs. Isabel Hudson is also an ambassador for the disability charity, SCOPE.

Chairwoman and director: National House Building Council (United Kingdom) 

Director: Phoenix Group Holdings Ltd (United Kingdom), RSA Insurance Group plc (Senior Independent Director) (United Kingdom), Standard Life PLC (United Kingdom)

Appointed on June 30, 2020 – Term expires at the 2024 Shareholders’ Meeting
First appointment on April 27, 2016
Member to the AXA Audit Committee
Number of AXA shares held on December 31, 2022: 7,250

Dr. Angelien Kemna graduated with a Master of Arts in Econometrics and a Ph.D. in Finance from Erasmus University Rotterdam (The Netherlands). She has a visiting scholar at the Sloan School, MIT (United States). Dr. Angelien Kemna began her career as Associate Professor in Finance at the Erasmus University from 1988 to 1991. In 1992, she joined Robeco NV and held various positions, notably Investments and Account Management Director from 1998 to 2001. During this period, she was also part-time Professor of Financial Markets at the University of Maastricht (The Netherlands) (1993–1999). From 2001 to July 2007, she worked for ING Investment Management BV (The Netherlands), where she initially held the position of Global Chief Investment Officer and subsequently Chief Executive Officer for the European Region. In the period 2007-2011, Dr. Angelien Kemna was part-time Professor of corporate governance at the Erasmus University and had also various non-executive and advisory positions, most notably Vice-Chairwoman of the Supervisory Board of the Dutch regulatory institution (AFM). In 2009, Dr. Angelien Kemna joined APG group NV as member of the Executive Board with the responsibility of Chief Investment Officer. From September 2014 to November 2017, Dr. Angelien Kemna was Chief Finance & Risk Officer of APG group (The Netherlands).

Director: AXA, AXA Investment Managers (Senior Independent Director)

Director or member of the Supervisory Board: NIBC (The Netherlands), Friesland Campina N.V. (The Netherlands), Naspers (South Africa), Prosus (The Netherlands)

Director: Railway Pension Investments Ltd (RPMI) (United Kingdom)

The Panel is composed of 7 permanent external members, each with a mandate of 3 years, renewable twice.

Stakeholder advisory panelists

Appointed on April 29, 2021 - Term expires at the 2025 Shareholders' Meeting

Member of the AXA Finance & Risk Committee

Number of AXA shares held on December 31, 2022: 38,234

Mr. Ramon de Oliveira is a graduate of the University of Paris and of the Institut d’études politiques (Paris). Starting in 1977, Mr. Ramon de Oliveira spent 24 years at JP Morgan & Co. From 1996 to 2001, Mr. Ramon de Oliveira was Chairman & Chief Executive Officer of JP Morgan lnvestment Management. Mr. Ramon de Oliveira was also a member of the firm’s Management Committee since its inception in 1995. Upon the merger with Chase Manhattan Bank in 2001, Mr. Ramon de Oliveira was the only executive from JP Morgan & Co. asked to join the Executive Committee of the new firm with operating responsibilities. Between 2002 and 2006, Mr. Ramon de Oliveira was an Adjunct Professor of Finance at both Columbia University and New York University. Mr. Ramon de Oliveira is the Founder and Partner of the consulting firm RdeO Consulting LLC, based in New York. Until October 22, 2021, he was Chairman of the Board of Directors of Equitable Holdings (EQH) and AllianceBernstein (AB), both based also in New York.

Founder and Partner: RdeO Consulting LLC (United States) (formerly Investment Audit Practice, LLC)

Member of the Investment Committee: Polish-American Freedom Fund

Chairman of the Board of Directors: AllianceBernstein Corporation (United States), Equitable Holdings, Inc. (United States), Friends of Education (non-profit organization) (United States)

Trustee and Chairman of the Investment Committee: Fondation Kaufman (United States)

Chairman of the Investment Committee: Fonds de Dotation du Musée du Louvre

Vice-Chairman: JACCAR Holdings SA (Luxembourg)

Director or member of the Supervisory Board: American Century Companies Inc. (United States), AXA Equitable Life Insurance Company (United States), AXA Financial, Inc. (United States), JP Morgan Switzerland (Switzerland), MONY Life Insurance Company (United States), MONY Life Insurance Company of America (United States), Quilvest (Luxembourg), SunGard Data Systems (United States), Taittinger-Kobrand USA (United States)

Member of the Investment Committee: La Croix Rouge (United States)

Appointed on April 28, 2022 - Term expires at the 2026 Shareholders’ Meeting
 First appointment on April 28, 2022
 Member of the Audit Committee
 Number of AXA shares held on December 31, 2022: 500

Mrs. Rachel Picard graduated from the École des hautes études commerciales (HEC) of Paris. From 1988 to 1991, she was Deputy Sales Manager at Valle Nevado, a ski resort located in Chile. From 1991 to 1993, Mrs. Rachel Picard worked at Eurodisney and in 1993, she joined Frantour (SNCF group, then Accor group), successively as marketing manager (1993-1995), marketing and communications director (1995-1997) and European Tour Operating director (1997-2000). From 2000 to 2004, she was Chief Executive Officer of Atlas Voyages. In 2004, Mrs. Rachel Picard joined the SNCF as Deputy Chief Executive Officer (Directrice Générale Adjointe) and then Chief Executive Officer of Voyages-SNCF.com (2007-2010). From October 2010 to April 2012, Mrs. Rachel Picard was Chief Executive Officer of Thomas Cook France. Then, she was Chief Executive Officer of SNCF Gares & Connexions from June 2012 to September 2014. From October 2014 to February 2020, she was Chief Executive Officer of SNCF Voyages (TGV). In June 2017, she was appointed member of the Board of Directors of Criteo and became Chairwoman of the Board of Directors in July 2020.

Chairwoman of the Board of Directors: Criteo

Member of the Supervisory Board: Rocher Participations 

Chief Executive Officer: SNCF Voyages (TGV)

Director: Compagnie des Alpes, Eurostar Group, Thalys, SNCF e-voyageurs

Appointed on June 30, 2020 - Term expires at the 2024 Shareholders’ Meeting
First appointment on June 30, 2020
Member of the Compensation, Governance & Sustainability Committee
Number of AXA shares held on March 31, 2023: 3,531

Mrs. Marie-France Tschudin graduated with a Master of Business Administration from IMD business school in Switzerland, and a Bachelor of Science from Georgetown University in the United States. Before joining Novartis, Mrs. Marie-France Tschudin spent 10 years at Celgene International in a variety of leadership positions across Europe. She joined Novartis in 2017 as Europe Region Head of Novartis Pharmaceuticals. From March to June 2019, she was President of Advanced Accelerator Applications, a Novartis company. In June 2019, she became President of Novartis Pharmaceuticals. As of April 4, 2022, Mrs. Marie-France Tschudin has been President, Innovative Medicines International & Chief Commercial Officer of Novartis Pharma AG (Switzerland) and a member of the Executive Committee of Novartis (Switzerland).

President, Innovative Medicines International & Chief Commercial Officer: Novartis Pharma AG (Switzerland)

President: Novartis Pharmaceuticals (Switzerland) 

Director: European Federation of Pharmaceutical Industries and Associations (EFPIA) (Belgium), IMD Foundation (Switzerland)

AXA

About AXA

Members of the Board of Directors

Antoine Gosset-Grainville

Thomas Buberl

Martine Bièvre

Helen Browne

Bettina Cramm

Clotilde Delbos

Rachel Duan

Guillaume Faury

Ramon Fernandez

André François-Poncet

Gérald Harlin

Isabel Hudson

Dr. Angelien Kemna

Ramon de Oliveira

Rachel Picard

Marie-France Tschudin